Literature DB >> 1712819

Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma.

F J Tefany1, R S Barnetson, G M Halliday, S W McCarthy, W H McCarthy.   

Abstract

Spontaneous regression occurs in a small proportion of malignant melanomas, and it is important to understand the processes involved in its induction as this may give a guide to future therapies for this disease. We have examined 36 primary malignant melanomas (19 regressing, 17 non-regressing) and identified the cellular phenotypes and activation states of the cells infiltrating regressing and non-regressing primary melanomas by immunochemistry. We have found a significantly increased number of CD3-positive cells and an increased ratio of CD4/CD8-positive cells infiltrating regressing compared to non-regressing tumors. In addition, the expression of the interleukin 2 receptor, an activation marker for T cells, was increased. However, there were no significant differences in class II MHC, CD1, intercellular adhesion molecule 1 (ICAM1), or melanoma-associated differentiation-antigen expression in these tumors. These data are consistent with melanoma regression being induced by activated CD4 T cells and do not seem to be related to the differentiation markers we have examined on these tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712819     DOI: 10.1111/1523-1747.ep12479662

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

1.  The significance of inflammation and regression in melanoma.

Authors:  M G Cook
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Gastrointestinal bleeding as the first manifestation of a burned-out tumour of the testis.

Authors:  Cecilia Castillo; Gabriel Krygier; Julio Carzoglio; Raúl Cepellini Magariños; Raúl Cepellini Olmos; Juan Jubín; Graciela Sabini
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

3.  Regulation of local and metastatic host-mediated anti-tumour mechanisms by L-selectin and intercellular adhesion molecule-1.

Authors:  M Yamada; K Yanaba; M Hasegawa; Y Matsushita; M Horikawa; K Komura; T Matsushita; A Kawasuji; T Fujita; K Takehara; D A Steeber; T F Tedder; S Sato
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 4.  Melanoma vaccines. Current status and future prospects.

Authors:  P Hersey
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

5.  Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression.

Authors:  J C Becker; A Schwinn; R Dummer; G Burg; E B Bröcker
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 6.  Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.

Authors:  Susan N Thomas; Nathan A Rohner; Erin E Edwards
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

Review 7.  Immunotherapy as a Potential Treatment for Chordoma: a Review.

Authors:  Shalin S Patel; Joseph H Schwab
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

8.  Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.

Authors:  M R Hussein; D A H Elsers; S A Fadel; A-E M Omar
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

9.  [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].

Authors:  B E Paredes
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

10.  Burned-out testicular tumor with retroperitoneal lymph node metastasis: a case report.

Authors:  Stylianos Kontos; Grigorios Doumanis; Maria Karagianni; Vasilios Politis; Vasileios Simaioforidis; Stefanos Kachrilas; Sotirios Koritsiadis
Journal:  J Med Case Rep       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.